RS Group PLC on Thursday said like-for-like sales returned to growth in the second quarter of the financial year despite ‘continued uncertainty’ in most markets.
Hikma Pharmaceuticals PLC on Thursday reduced medium term guidance and cut the top-end of its 2025 core operating profit view amid a delayed start to...